Strategic Guru

Niiki Pharma Inc. announced that results from the completed Phase I dose escalation trial of its GRP78 targeted anti-cancer agent, NKP-1339, will be presented at the Annual Meeting of the American Society of Clinical Oncology to be held in Chicago.

Niiki Pharma announced the presentation of preclinical data at the American Association for Cancer Research Annual Meeting in Chicago, Illinois for its novel compound, NKP-2235, the first highly orally bioavailable gallium-based anti-cancer agent.

Niiki Pharma announced today the formation of its Scientific Advisory Board. Daniel Haller M.D. will chair the advisory board, and will be joined by Lee Ellis M.D. and Matt Kulke M.D. The Board will provide clinical and strategic guidance.

Niiki Pharma Inc. announced today that it has completed the dose escalation portion of the Phase I clinical trial of its lead product, NKP-1339, a first-in-class small molecule that down-regulates GRP78, a key tumor survival and anti-apoptosis factor

An abstract given at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics demonstrated NKP-1339’s synergistic activity in both in vitro and in vivo preclinical models with a broad range of anti-tumor agents.

Phase I clinical trial results of the first-in-class cancer agent show 25% of enrolled patients (six) exhibiting anti-tumor activity for at least 12 weeks. One patient with a carcinoid tumor has tumor regression, continuing on NKP-1339 for 70+ weeks.

LORRAINE JOHNSON CFP®, CFA OF TRIANGLE FINANCIAL ADVISORS named 2011 National Association of Women Business Owners Member of the Year and was recognized for her commitment to the organization and support of business owners in the Raleigh chapter.

LORRAINE JOHNSON CFP®, CFA OF TRIANGLE FINANCIAL ADVISORS hosted a presentation by Elizabeth Dooley, CFA, Portfolio Manager with Rochdale Investment Management in New York, NY on the economic outlook and sustained expansion of investments.

Grant to Fund Agency’s Reduce, Reuse, Recycle Education Plan

Firm provided ground up technology infrastructure for Centennial Campus location